Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for CRISPR-Therapeutics
Company Monitoring Page for CRISPR-Therapeutics
latest headlines for company on cafepharma
Is anyone taking the world’s priciest drugs?
Pharma Voice
Fri, 08/30/24 - 11:28 am
Tags:
drug prices
,
gene therapy
,
CRISPR Therapeutics
,
Vertex Pharmaceuticals
,
Sarepta Therapeutics
FDA awarded record number of review designations to CRISPR drugs in 2023
Biopharma Reporter
Tue, 02/6/24 - 09:16 am
Tags:
CRISPR
,
FDA
,
gene editing
,
CRISPR Therapeutics
,
Vertex Pharmaceuticals
Where Will CRISPR Therapeutics Be in 5 Years?
Motley Fool
Wed, 01/24/24 - 10:54 am
Tags:
CRISPR Therapeutics
,
gene editing
,
CRISPR
What’s Next for CRISPR?
BioSpace
Tue, 01/23/24 - 06:00 pm
Tags:
CRISPR
,
gene editing
,
Vertex Pharmaceuticals
,
CRISPR Therapeutics
Could Editas Medicine Become the Next CRISPR Therapeutics?
Motley Fool
Sun, 01/21/24 - 05:01 pm
Tags:
Editas Medicine
,
gene editing
,
CRISPR Therapeutics
FDA widens approval of Vertex’s CRISPR medicine to treat beta thalassemia
BioPharma Dive
Wed, 01/17/24 - 09:34 am
Tags:
Vertex Pharmaceuticals
,
CRISPR Therapeutics
,
Casgevy
,
beta thalassemia
,
FDA
Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval
Clinical Trials Arena
Wed, 01/17/24 - 09:30 am
Tags:
CRISPR
,
gene editing
,
clinical trials
,
Casgevy
,
Vertex Pharmaceuticals
,
CRISPR Therapeutics
,
EdiGene
,
Shanghai Vitalgen BioPharma
,
Regeneron
,
Vor Biopharma
5 FDA Decisions to Watch in Q1
BioSpace
Tue, 01/2/24 - 11:24 am
Tags:
FDA
,
Iovance Biotherapeutics
,
melanoma
,
lifileucel
,
Minerva Neurosciences
,
schizophrenia
,
roluperidone
,
Viatris
,
Mapi Pharma
,
MS
,
multiple sclerosis
,
GA Depot
,
Madrigal Pharmaceuticals
,
NASH
,
resmetirom
,
Vertex Pharmaceuticals
,
CRISPR Therapeutics
,
exa-cel
,
beta thalassemia
CRISPR eyes autoimmune disease in revamp of cell therapy plans
BioPharma Dive
Tue, 12/5/23 - 11:38 am
Tags:
CRISPR Therapeutics
,
cell therapy
,
autoimmune disease
,
cancer
What to know about the U.K.’s approval of the first CRISPR treatment for diseases
Nature
Fri, 11/17/23 - 10:05 am
Tags:
UK
,
CRISPR
,
gene editing
,
Casgevy
,
Vertex Pharmaceuticals
,
CRISPR Therapeutics
Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK
BioSpace
Thu, 11/16/23 - 10:21 am
Tags:
CRISPR
,
gene editing
,
Vertex Pharmaceuticals
,
CRISPR Therapeutics
,
UK
,
Casgevy
,
beta thalassemia
Cell & Gene Therapy Space Gears Up for First CRISPR Approval
BioSpace
Mon, 11/13/23 - 11:48 am
Tags:
CRISPR
,
gene therapy
,
cell therapy
,
sickle cell disease
,
exa-cel
,
Vertex Pharmaceuticals
,
CRISPR Therapeutics
Two Sickle Cell Disease Gene Therapies May Soon Be Approved By FDA
Forbes
Thu, 11/2/23 - 05:07 pm
Tags:
sickle cell disease
,
gene therapy
,
lovo-cel
,
exa-cel
,
Vertex Pharmaceutical
,
CRISPR Therapeutics
,
Bluebird Bio
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
Yahoo/Reuters
Tue, 10/31/23 - 09:23 pm
Tags:
Vertex Pharmaceuticals
,
CRISPR Therapeutics
,
FDA
,
gene therapy
,
exa-cel
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
Tags:
FDA
,
Alnylam
,
Onpattro
,
ATTR amyloidosis
,
Vertex Pharmaceuticals
,
CRISPR Therapeutics
,
exa-cel
,
Bluebird Bio
,
Zynteglo
,
sickle cell disease
,
Bristol Myers Squibb
,
2seventy bio
,
Abecma
,
Multiple Myeloma
,
Amgen
,
Lumakras
,
non-small cell lung cancer
,
Pfizer
,
estrasimod
,
ulcerative colitis
This 1 Innovation Could Make These 2 Biotechs Soar by 2030
Motley Fool
Sun, 07/23/23 - 12:28 pm
Tags:
cell therapy
,
Caribou Biosciences
,
CRISPR Therapeutics
U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million
Reuters
Fri, 07/14/23 - 10:07 am
Tags:
ICER
,
gene therapy
,
Vertex Pharmaceuticals
,
CRISPR Therapeutics
,
Bluebird Bio
,
drug pricing
,
sickle cell disease
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
Tags:
FDA
,
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
,
SAGE Therapeutics
,
zuranolone
,
postpartum depression
,
major depressive disorder
,
Roche
,
Tecentriq
,
non-small cell lung cancer
,
CRISPR Therapeutics
,
Bluebird Bio
,
lovo-cel
,
exa-cel
,
BrainStorm Cell Therapeutics
,
NurOwn
Gene Editing Race Between Editas and Vertex, CRISPR Heats Up
BioSpace
Mon, 06/12/23 - 09:58 am
Tags:
gene editing
,
Editas Medicine
,
Vertex Pharmaceuticals
,
CRISPR Therapeutics
,
EDIT-301
,
sickle cell disease
,
beta thalassemia
Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins, PDUFA date granted
Fierce Biotech
Fri, 06/9/23 - 10:07 am
Tags:
Vertex Pharmaceuticals
,
CRISPR Therapeutics
,
CRISPR
,
gene editing
,
FDA
,
sickle cell disease
,
beta thalassemia
Pages
1
2
3
4
5
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.